| Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 69.75 mm | 69.75 mm | 69.75 mm | 69.75 mm | 69.75 mm | 69.75 mm |
| Cash burn (monthly) | (no burn) | 49.67 k | 25.74 mm | 38.55 mm | 18.55 mm | 19.55 mm |
| Cash used (since last report) | n/a | 944.87 k | 489.77 mm | 733.46 mm | 352.96 mm | 371.97 mm |
| Cash remaining | n/a | 68.80 mm | -420.02 mm | -663.71 mm | -283.21 mm | -302.22 mm |
| Runway (months of cash) | n/a | 1385.3 | -16.3 | -17.2 | -15.3 | -15.5 |
| 13F holders | Current |
|---|---|
| Total holders | 9 |
| Opened positions | 1 |
| Closed positions | 1 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 214.38 mm |
| Total shares | 48.03 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Ics Opportunities | 14.52 mm | $2.40 mm |
| Xianjian Advanced Technology | 7.34 mm | $51.77 mm |
| Famous Sino | 5.96 mm | $40.71 mm |
| China In Shine Investment | 4.76 mm | $32.49 mm |
| Ally Bridge Group Capital Partners II | 4.45 mm | $12.10 mm |
| Hongguo International | 4.07 mm | $27.81 mm |
| Asia Pacific MedTech | 3.55 mm | $24.22 mm |
| Magnum Opus 2 International | 3.34 mm | $22.82 mm |
| HighPoint Advisor | 22.25 k | $60.00 k |
| Proequities | 0.00 | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 Oct 23 | Sorrento Therapeutics | Class A Common Stock | Sell | Dispose S | No | No | 0 | 6,307,158 | 0.00 | 5,050,427 |
| 29 Sep 23 | Sorrento Therapeutics | Class A Common Stock | Sell | Dispose S | No | No | 0 | 9,064,539 | 0.00 | 11,357,585 |
| 21 Sep 23 | Sorrento Therapeutics | Common Stock | Sell | Dispose S | No | No | 0 | 60,068,585 | 0.00 | 1,917,210 |
| 21 Sep 23 | Sorrento Therapeutics | Warrants to Purchase Common Stock Common Stock | Sell | Dispose S | No | No | 11.5 | 4,490,617 | 51.64 mm | 0 |
